Literature DB >> 27123566

Prospective memory impairment in chemotherapy-exposed early breast cancer survivors: Preliminary evidence from a clinical test.

Marc Bedard1, Shailendra Verma2, Barbara Collins3, Xinni Song2, Lise Paquet1.   

Abstract

We report the results of a secondary analysis of a cross-sectional study (Paquet et al., 2013 ) to evaluate the cognitive operations involved in prospective memory (PM) deficits exhibited by chemotherapy-exposed breast cancer (BC) survivors. PM was assessed with the memory for intentions screening test administered to 80 patients and 80 healthy controls. Patients performed worse than controls on the PM tasks and had more "omission" errors (indices of the prospective component of the tasks) than the controls. No group differences emerged on a recognition test. Although further studies will be needed to disentangle the multiple cognitive operations involved in PM, these findings are consistent with the notion that self-initiated retrieval processes rather than encoding are implicated in PM impairment among BC survivors.

Entities:  

Keywords:  breast cancer; chemobrain; chemotherapy; cognitive deficits; prospective memory impairment

Mesh:

Substances:

Year:  2016        PMID: 27123566     DOI: 10.1080/07347332.2016.1181133

Source DB:  PubMed          Journal:  J Psychosoc Oncol        ISSN: 0734-7332


  5 in total

1.  I could do it now, but I'd rather (forget to) do it later: examining links between procrastination and prospective memory failures.

Authors:  Sascha Zuber; Nicola Ballhausen; Maximilian Haas; Stéphanie Cauvin; Chloé Da Silva Coelho; Anne-Sophie Daviet; Andreas Ihle; Matthias Kliegel
Journal:  Psychol Res       Date:  2020-05-22

2.  The COMT (rs165599) gene polymorphism contributes to chemotherapy-induced cognitive impairment in breast cancer patients.

Authors:  Huaidong Cheng; Wen Li; Chen Gan; Bo Zhang; Qianqian Jia; Kai Wang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

3.  Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study.

Authors:  Mylène Duivon; Joy Perrier; Florence Joly; Idlir Licaj; Jean-Michel Grellard; Bénédicte Clarisse; Christelle Lévy; Philippe Fleury; Sophie Madeleine; Nicolas Lefèvre; Géraldine Rauchs; Grégory Lecouvey; Florence Fraisse; Fausto Viader; Francis Eustache; Béatrice Desgranges; Bénédicte Giffard
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

Review 4.  Episodic Memory and Recollection Network Disruptions Following Chemotherapy Treatment in Breast Cancer Survivors: A Review of Neuroimaging Findings.

Authors:  Meenakshie Bradley-Garcia; Gordon Winocur; Melanie J Sekeres
Journal:  Cancers (Basel)       Date:  2022-09-29       Impact factor: 6.575

5.  Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.

Authors:  Wen Li; Jingjing Zhao; Ke Ding; Herta H Chao; Chiang-Shan R Li; Huaidong Cheng; Li Shen
Journal:  Med Sci Monit       Date:  2020-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.